Unlike existing treatments that block individual cytokines such as IL-4, IL-13 or IL-31, therapies targeting the OX40 pathway ...

Nearly 1 in 10 U.S. adults report having physician-diagnosed chronic head eczema, according to findings from a ...

New long-term data of the investigational therapy icotrokinra show that it is able to achieve site-specific clear or almost clear skin in patients with plaque psoriasis, according to results of the ...

Shawn Kwatra, M.D., Joseph W. Burnett endowed professor and chair of dermatology at the University of Maryland School of ...

The use of interleukin (IL)-23 inhibitors plays an important role in treating patients with psoriasis, as well as in treating ...

Employer health premiums rose significantly this year, impacting healthcare costs and insurance access. A KFF survey reveals trends in coverage and employee contributions. Average annual premiums for ...

Foluso Agboola discusses the Institute for Clinical and Economic Review's newest analysis, which has found that most new ...

A new digital health tool increased rates of lung cancer screening, according to research published Oct. 20 in JAMA. Investigators from Wake Forest University School of Medicine, ...

Although it’s commonly recommended to test for albuminuria in people with diabetes or high blood pressure, testing is often ...

The oral microbiome is home to more than 700 species of bacteria, and the average person hosts approximately 250 species at a time, according to the study. Each person’s oral microbiome is unique and ...

Data analyses from two real-world trials of Rebyota (fecal microbiota, live-jslm)efficacy and safety will be presented at IDWeek 2025, according to the details of a recent Ferring Pharmaceuticals news ...

Patients with Type 1 diabetes are often excluded from diabetes and weight loss trials. Forty years ago, the vast majority of patients with Type 1 diabetes didn’t need help with the problem of being ...